[1]
« Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada », Can Allergy Immunol Today, vol. 5, nᵒ s01, p. 2–9, mars 2025, doi: 10.58931/cait.2025.5s0176.